Agoracom Blog Home

Posts Tagged ‘weed’

North Bud Farms Inc. $NBUD.ca – Study Says Canadian Cannabis Market Could Reach $5.2B By 2024: 4 Provinces To Watch $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 5:13 PM on Tuesday, April 9th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

NBUD: CSE

—————

Study Says Canadian Cannabis Market Could Reach $5.2B By 2024: 4 Provinces To Watch


Alex Oleinic , Benzinga Staff Writer  


  • In 2018, legal cannabis spending grew by 65 percent to $569 million.
  • Through legalizing adult-use cannabis, Canada created a market that covers nearly 30 million consumers.

On Oct. 17, 2018, Canada made history by becoming the first G7 country and the second country overall to legalize adult-use cannabis.

Yet the rollout of legal Canadian cannabis was fraught with shortages, a limited retail presence and poor product selection. 

In 2018, legal cannabis spending grew by 65 percent to $569 million. In the last two and a half months of 2018, adult-use sales reached $112.5 million, falling short of estimates.

Canadian spending on medical marijuana alone in 2017 grew by 84 percent to $330 million.

In a fairly short period of time, Canada has become the home to cannabis companies like Aurora Cannabis Inc. ACB 2.38%, Canopy Growth Corp CGC 2.17%, Tilray Inc. TLRY 0.56%, Cronos Group, Inc. CRON 0.8% that have risen to become the largest cannabis companies in capitalization terms. 

These firms are expanding their presence not just in Canada, but in other countries, either through exports or by establishing full-scale cultivation and distribution operations. No matter what occurs in the Canadian cannabis market, these companies have already established themselves as global leaders.

Provincial Rules, Regulations Are Key 

Through legalizing adult-use cannabis, Canada created a market that covers nearly 30 million consumers.

Shortages weren’t completely unexpected, given that the medical market had only included around 360,000 people.

The Canadian government allowed provinces to figure out how to deal with the legalization and consumption of cannabis.

Stricter rules in some provinces mean that overall cannabis spending might be affected, with more consumers continuing to access the illicit market and its lower prices.  

In a new report, Arcview Market Research and BDS Analytics project the legal cannabis market in Canada could reach $5.2 billion by 2024, with the bulk of the figure representing adult-use sales ($4.8 billion).

Arcview and BDS Analytics issued a province-by-province breakdown, to show that not only the role the population plays in the cannabis market’s size, but how regulations and the environment created by local government should also be taken into account.

Four Key Provinces

Arcview and BDS identified four main provinces that they project will dominate the market in spending in 2024: Ontario, Alberta, Quebec and British Columbia. These provinces will account for 85 percent of the market by 2024 versus around 82 percent in 2018, according to the report.

While Ontario is the largest market due to its high population and favorable business environment, Alberta is the second-largest, despite having the lowest population of the four provinces, the research firms said. 

Quebec is the second-largest province in terms of population, but ranks fourth in terms of market share. This figure is not only due to regulations, but also due to very low number of consumers.

Let’s take a closer look at how the cannabis market is projected to develop in each of these four provinces and the main factors affecting that growth. 

Ontario

Ontario is Canada’s most populous province, with 14.4 million people. At the same time, 26 percent of the population identifies themselves as cannabis consumers and 31 percent as acceptors, or people who would consider consuming in the future, according to BDS Analytics’ Consumer Insights. The Ontario cannabis market is expected to exceed $2 billion, with adult-use consumption accounting for $1.8 billion.

The province also has some of the more permissive rules regarding cannabis consumption. Smoking and vaping is allowed in public areas like parks and at designated rooms at hotels, motels and inns. Other than those provisions, public use is regulated in the same way as tobacco.

Another major factor that will help Ontario’s cannabis market growth: changes at the retail level. The government-run Ontario Cannabis Store is being replaced with private retailers, and officials have not set a cap on licenses, although they estimate between 500 and 1,000 locations will eventually open across the province.

Alberta

Alberta is Canada’s fourth-most populous province, with around 4.3 million people in 2018. Since legalization and through the end of 2018, the province registered 28 percent of the total cannabis sales in the country.

The province has a higher-than-average number of consumers (27 percent) and acceptors (32 percent), BDS and Arcview said.

In Alberta, adult-use cannabis is available to people above 18 years of age versus 19 years in Ontario and British Columbia.

The main factor helping Alberta’s cannabis market is the favorable business environment. Following legalization, regulators in Alberta quickly allowed private retailers to enter the market. Two hundred adult-use stores are expected in Alberta, compared to an average of 50 stores in other provinces.

Quebec

Quebec is expected to represent less than 14 percent of the Canadian cannabis market in 2024.

Even though it’s the second-largest province in terms of population, only 20 percent of residents are consumers and it is home to just 3 percent of registered medical patients. Quebec is reportedly considering raising the legal age of consumption fro 18 to 21. Total cannabis spending is expected to reach $704 million in 2024.

Quebec has stricter distribution regulations. Retail is conducted through Société Québécoise du cannabis, which initially opened just 12 stores and doesn’t conduct any advertising. To deal with shortages, SQDC limited the days of operation to Thursday through Saturday, although online sales remain open at all times.

British Columbia

Even though its population is much smaller than Quebec’s  —5 million vs. 8.3 million — British Columbia is projected to amass 14% of total Canadian cannabis spending in 2024, slightly more than in Quebec. Legal sales are expected to reach $722 million by 2024.

Retail sales in British Columbia are conducted both through province-run and private stores. Earlier this year, the British Columbia Liquor Distribution Branch, which is the sole wholesale distributor of non-medical cannabis, partnered with 31 large licensed producers, including Canopy Growth, which operates the largest cannabis greenhouse in the world in the province.

What To Keep In Mind

While provincial regulations may slow down cannabis market growth in Canada, it’s still poised to grow at at an impressive rate, as more products become available sometime later this year and more retailers are allowed to set up locations across provinces.

In the meantime, the legalization of adult-use cannabis in Canada and a regulatory system that gives some degree of leeway to provinces or even municipalities are providing a case study to the rest of the world to see which approaches work best at ensuring safety and quality — and which should be avoided.

Source: https://www.benzinga.com/markets/cannabis/19/04/13504767/study-says-canadian-cannabis-market-could-reach-5-2b-by-2024-4-provinces-to-watch

North Bud Farms Inc. $NBUD.ca – #Cannabis Canada Daily: Pent-up demand leads to roaring start for Ontario #pot stores $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 11:02 AM on Monday, April 8th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

NBUD: CSE

—————

Cannabis Canada Daily: Pent-up demand leads to roaring start for Ontario pot stores

Ontario pot shops made an average of $50K in sales on the first day of business

Data from Cova Software, which provides point-of-sale services to seven of the 10 recreational cannabis stores in Ontario, reveal that legal cannabis shops in the province made an average of $50,913 of sales on opening day.

Source: https://www.bnnbloomberg.ca/marijuana/video/ontario-pot-shops-sold-an-average-of-50k-on-the-first-day-of-business~1652388

North Bud Farms Inc. $NBUD.ca – Edible Arrangements: The Global Cannabis Edibles Market $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:53 AM on Tuesday, April 2nd, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

NBUD: CSE

—————

Edible Arrangements: The Global Cannabis Edibles Market

  • The global cannabis edibles market is one of the most promising segments of the overall industry, presenting a world of opportunity for cannabis edibles companies to set themselves apart with unique and appealing products.
  • For cannabis connoisseurs, cannabis edibles have always been an alluring proposition.

For cannabis connoisseurs, cannabis edibles have always been an alluring proposition. Take something you already enjoy, and add it to something delicious. What’s not to like? The classic “special brownie” and the famous “space cakes” that have been enjoyed at Amsterdam coffee shops for decades are only just the tip of the edibles iceberg. Today, cannabis is being added to candy, artisanal baked goods, coffee, jerky, pizza, upscale cuisine and so much more, meaning the possibilities are endless for the global cannabis edibles market.

It’s no surprise that the Canadian legal cannabis industry is hungrily eyeing cannabis edibles as they promise to account for a huge portion of the overall cannabis market as soon as Health Canada allows it. In the meantime, however, this highly promising market segment faces some significant regulatory challenges. That won’t stop companies from taking an interest in edibles, as they already make up a huge portion of the market in legal jurisdictions where they are allowed, such as California and Nevada.

Edibles to take cannabis market by storm

The consumer appeal of edibles is obvious. The sheer amount of variability creates countless possibilities for cannabis companies looking to make their products stand out. Edibles can be tailored to any type of cannabis consumer, from high-end dark chocolates served at posh dinner parties to gummy candies enjoyed before a rock concert. It’s easy to make edible cannabis products eye catching and appealing. For newcomers trying cannabis for the first time after legalization, edibles may provide a less intimidating entry point than smoking or vaping. And medical users often appreciate the stronger and longer-lasting effect of orally ingested cannabis.

An October 2018 report by ArcView Market Research and BDS Analytics projects the North American cannabis edibles market to hit more than $4.1 billion by 2022. According to the report, food and drink products accounted for approximately 11.4 percent of total cannabis spending in Canada and the United States in 2017. As the cannabis market matures and develops, and as edible products return to dispensary shelves in Canada, classic dried cannabis flower is expected to steadily lose market share to edibles and extracts.

Regulatory challenges and solutions

Right now in Canada, though, the more immediate future of the cannabis edibles market is less certain. Edibles were not included in the first wave of cannabis legalization that took place in October 2018, with Health Canada opting to conduct further study and consultation before rolling out regulatory rules by October 2019. This put a wrench in the gears for the hundreds of cannabis companies that had made edibles a key part of their initial business strategy. In early 2019, Health Canada began a two-month public consultation period as part of the process of determining the edibles regulatory scheme. By all accounts, the restrictions are likely to be heavy. Chief among the rules will be restrictions on potency and mandates on accurate potency labeling.

The concerns over potency and accurate labeling aren’t entirely unwarranted. Cannabis edibles have always been tricky in the way they hit the user. Cannabis ingested through the digestive system can take an hour or more to for the user to notice the effect, and inexperienced users have commonly been known to make the rookie mistake of taking more under the belief that they haven’t taken a high enough dosage. Due to the intense nature of edible products, the appeal of edibles to inexperienced cannabis users in particular can be a recipe for disaster. Excessive dosage of cannabis is not highly dangerous in that it will not cause poisoning or other health emergencies, but cannabis-related panic attacks can still present a risk.

This is why cannabis companies that plan on making edibles a significant part of their business model have dedicated considerable resources to developing precision dosing technology. The challenge stems from the fact that the rate in which cannabis breaks down as it enters the bloodstream varies significantly based on a number of factors, including the specific physiology of the consumer.

Recent years have seen the development of tools for manipulating cannabis at the molecular level for greater bioavailability, allowing edibles manufacturers to provide a more predictable product for easier regulatory compliance and greater consumer trust.

Regulators have been placing a range of other regulatory hurdles in the way of the edibles market. Health Canada is expected to enforce tight restrictions on edibles packaging, limiting the use of colorful graphics and other eye-catching elements largely with the intent of limiting the products’ appeal to children. Packaging will also need to be child resistant. Regulators in various jurisdictions have often restricted potency, with Health Canada expected to limit products to 10 milligrams of THC per dose. Similarly, California has focused its regulations around keeping cannabis edibles out of the hands of children with a universal cannabis product symbol, a government warning, child-proof packaging and clear labeling for potency and recommended dosage.

Takeaway

Not every cannabis consumer is particularly interested in smoking or vaping, but everyone is interested in tasty treats. Meeting regulatory hurdles for dosing and keeping products out of the hands of children has been a challenge, but these challenges hardly reduce the potential of what promises to be, and in many jurisdictions already is, one of the primary market segments of the cannabis industry.

Source: https://investingnews.com/innspired/global-cannabis-edibles-market/

Bougainville Ventures $BOG.ca Begins Site Preparation in Washington State, Oroville Campus $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 4:29 PM on Monday, April 1st, 2019
  • Announced that its first 10,000 square foot cultivation facility in Oroville, WA will be occupied by a Tier-3, I-502 tenant starting June 01, 2019.
  • Tenant is currently in the process of obtaining occupancy approval from the Washington State Liquor and Cannabis Board to begin planting the Tenant’s crop for the season.
  • In addition to the 10,000 sq. ft. space, Tenant is planning to plant a 20,000 sq. ft. out-door crop. The Tenant is licensed to build out up to 30,000 square feet on the existing property in Oroville, WA.

VANCOUVER, British Columbia, April 01, 2019 – BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE: BOG), providing cannabis infrastructure and seed-to-sale services to I-502 tenant-growers, is pleased to announce that its first 10,000 square foot cultivation facility in Oroville, WA will be occupied by a Tier-3, I-502 tenant (the “Tenant”) starting June 01, 2019. The Tenant is currently in the process of obtaining occupancy approval from the Washington State Liquor and Cannabis Board (WSLCB) to begin planting the Tenant’s crop for the season. In addition to the 10,000 sq. ft. space the Tenant is planning to plant a 20,000 sq. ft. out-door crop. The Tenant is licensed to build out up to 30,000 square feet on the existing property in Oroville, WA.

CEO, Andy Jagpal Comments: 
“We are excited to see our first Tier-3, I-502 tenant move forward towards a successful growing season. This first planting season signals a new phase for Bougainville concept of providing fully built out turnkey facilities to cannabis growers and processors.These facilities remove financial barriers for cannabis cultivators as traditional funding can be limited. In addition, steps are being taken to get a second tenant up and running for the 2019 growing season. We are moving towards our goal of revenue generating self-sufficiency.”

About the Washington I-502 Marijuana Market 
In November 2012, the Washington State Liquor Control Board (WSLCB) passed Initiative 502 (I-502) pursuant to a vote by the people of the State of Washington. I-502 authorized the WSLCB to regulate and tax recreational marijuana products for persons over twenty-one years of age and thereby created a new industry for growing, processing and selling of Washington State-regulated recreational marijuana products. A recent WSLCB commissioned report by the Rand organization suggests that there are currently up to 650,000 recreational marijuana users in Washington State, worth approximately $1.25 – $1.5 billion USD in annual sales. 

About Bougainville Ventures, Inc. 
Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost. Bougainville has 10,000 sq.ft., in near production in Oroville, WA, sufficient land for two more pods of the same size.

For more information please visit: http://bougainvilleinc.com/ 

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC. 
_____________________
Andy Jagpal, CEO and Director 

For further information, please contact the IR department at [email protected] or by phone at 1-877-517-7816.

North Bud Farms Inc. $NBUD.ca – Marijuana edibles: Is Canada on track to legalize them? $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:00 AM on Friday, March 29th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

NBUD: CSE

—————

Marijuana edibles: Is Canada on track to legalize them?

  • In a second wave of recreational legalization in Canada, cannabis edibles will be permitted for legal sale no later than Oct. 17, 2019, Health Canada has confirmed. And the market is up for grabs.
  • The edibles industry is expected to be worth $4.1 billion in Canada and the United States by 2022, according to a report by a marijuana market research company called The Arcview.

By Emanuela Campanella Multimedia Video Journalist  Global News

In a second wave of recreational legalization in Canada, cannabis edibles will be permitted for legal sale no later than Oct. 17, 2019, Health Canada has confirmed. And the market is up for grabs.

The edibles industry is expected to be worth $4.1 billion in Canada and the United States by 2022, according to a report by a marijuana market research company called The Arcview.

As of now, in Canada, you can make cannabis-infused food at home but it is illegal for anyone to buy and or sell them to the public.

Canada’s proposed edible pot regulations have been published by Health Canada and the 60-day consultation process has come to an end. The public health agency is now reviewing the responses.

The draft regulations

Under the proposed federal rules, a single serving would be limited to 10 milligrams of THC, the psychoactive ingredient in cannabis, and each serving must be individually wrapped. This is considered a low to moderate dose of THC.

This dosage limit is stricter than in Colorado, Washington or California, where multiple servings are allowed per package. So for example in a chocolate bar, each breakable square can contain 10 milligrams each for a total of 100 milligrams.

Pot meant for ingestion cannot have alcohol, have limited caffeine and come in a plain, child-resistant package. The draft regulations say the products must not be appealing to youth and the packaging can’t advertise dessert or confectionery flavours — so no gummies shaped like bears.

The proposed rules are an attempt to address one of the main concerns with edibles: making sure it doesn’t pose a risk to public health, especially for those who are underage.

“In other jurisdictions, which legalized marijuana just like the states in the U.S., one of the problems, [with] legalizing edibles, were kids. So kids came into the kitchen saw this wonderful nicely coloured marijuana edible and as kids do, try it out,” said Dr. Jürgen Rehm, a senior scientist at the Institute for Mental Health Policy Research at CAMH.

However, some are worried the black market will continue to thrive with such strict regulations. In California, for example, which legalized recreational marijuana and edibles last year, industry experts say the illicit market continues to boom. 

One major cannabis edibles manufacturer in California says it’s been difficult to navigate within the legal market because there is still so much competition in the illicit market.

“People that are heavy consumers of THC and like to ingest it, can ingest hundreds if not thousands of milligrams of THC in a day and so if they have products that are available in the illicit market that are much cheaper and have a higher potency, they’re going to tend to go towards that rather than paying significantly more for less THC, which is what they’ve used to consume,” Bryce Berryessa said, the president of La Vida Verde.

WATCH: Is marijuana good or bad for you? Everything we know about the health effects of cannabis

Berryessa says your body builds up a pretty quick tolerance when ingesting edibles. So a lot of those people who are currently used to consuming a higher amount of THC are still participating in the illegal market to get access to products with higher potencies.

Rehm who has been working on the field of mental health and cannabis consumption says it’s better to have an incremental approach when it comes to edibles.

“The problem with edible marijuana is that people are not used to it. A lot of the people once they smoke marijuana. They feel the effects pretty quickly. With edibles, the effects can be later. And people say ‘Oh, I have now done this edible marijuana and I feel nothing’ and they have more and more,” Rehm said. 

To avoid putting people at risk, it would be better to start with a low dosage and once we have clear evidence the black market is still thriving, then we can re-evaluate it, he added. 

“So with all the legislation, with all the upper limits of THC or other points, we have to be in a way so we can reap the benefits of legalization (i.e safer product and not lose some of the consumers to the black market). And frankly, I think there will be a lot of trial and error in the next one to two years.”

Health Canada confirms that they have received 7,000 responses from Canadians, industry representatives, the provinces and the public health community on the proposed edibles draft regulations. Now, the agency is reviewing the comments and considering where adjustments can be made.

Those in the marijuana industry, however, are skeptical the government will make the edibles deadline set for themselves. When it came to recreational pot, legalization was first promised on Canada day, but the actual date wasn’t for a couple of months later.

Health Canada could not comment on when we will see the updated draft but confirmed that cannabis products will be permitted for legal sale no later than Oct. 17, 2019.

Source: https://globalnews.ca/news/5096541/marijuana-cannabis-edibles-canada/

#Marijuana Company of America $MCOA Successfully Launches hempSMART CBD Products at UK Event $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:16 AM on Thursday, March 28th, 2019
  • Successfully launched sales of the hempSMART™ product line in the United Kingdom during the London event on March 23, 2019.
  • The hempSMART UK team successfully sold out its entire promotional inventory at the launch event, which led to over 1,000 new associates signing up with the Company’s associate networking program.

Escondido, California–(March 28, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s wholly owned subsidiary, hempSMART, Ltd., has successfully launched sales of the hempSMART™ product line in the United Kingdom during the London event on March 23, 2019.

The hempSMART UK team successfully sold out its entire promotional inventory at the launch event, which led to over 1,000 new associates signing up with the Company’s associate networking program. The official website of hempSMART UK is live and can be visited at www.hempsmart.co.uk.

The event in London is being followed up by additional launch events taking place in Birmingham and Liverpool. Due to the success of our United Kingdom launch, the Company anticipates that the pre-launch for the hempSMART product line will take place in the Netherlands and Germany during Q2 2019.

Global Sales Director for hempSMART™, Ian Harvey, said, “Our First Launch event was a huge success as we had to close registrations due to the hotel capacity being reached. To avoid disappointment, we have now scheduled two further launch events in Birmingham and Liverpool. These events are filling fast and are both on track to be sold out despite booking larger venues. I was just nineteen when I first got involved in MLM and I have never experienced this level of excitement involving a launch. With the next two venues filling up I truly believe that hempSMART™ will become a household name across Europe very quickly.”

CEO of MCOA, Donald Steinberg, stated, “We are delighted to have launched our CBD product line hempSMART™ internationally this past week. HempSMART™ will continue to put in place the proper preparations to launch in additional EU countries moving forward.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/43682

Bougainville Ventures Inc $BOG.ca – The #marijuana industry looks like the fastest-growing job market in the U.S #weed $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:00 PM on Sunday, March 17th, 2019
SPONSOR:  Bougainville Ventures Inc (CSE: BOG) Converting irrigated farmland to greenhouse-equipped farmland. Bougainville does not “touch the plant” and only provides agricultural infrastructure as a landlord for licensed marijuana growers. Click here for more info.
BOG:CSE
—————————————

The marijuana industry looks like the fastest-growing job market in the U.S

  • The marijuana industry added 64,389 jobs in 2018, a 44 percent gain, according to industry experts Leafly and Whitney Economics.
  • Economists believe the U.S. job market overall is getting tight, evidenced by the 20,000 growth in payrolls for February
  • Job creation is expected to grow as more states legalize pot. Nick Colas at DataTrek Research said cannabis is the “fastest-growing labor market in the U.S.”

Jeff Cox | @JeffCoxCNBCcom

Published 19 Hours Ago Updated 17 Hours Ago CNBC.com

Tom Franck | CNBC Canopy Growth operations in Smiths Falls, Ontario.

At a time when the rest of the labor market appears to be tightening up, the marijuana industry is just getting started when it comes to job creation, according to a recent report.

Pot manufacturers and distributors, on both the recreational and medicinal sides, saw massive job creation in 2018, with 64,389 new positions added to the rolls. That brings to 211,000 the number of jobs directly related to the industry, part of a total of 296,000 in all related areas combined, industry site Leafly said in a report it compiled with Whitney Economics.

The U.S. economy in total created about 2.7 million new jobs in 2018, according to the Bureau of Labor Statistics, which does not count cannabis-related hiring because the substance is still considered a Schedule 1 narcotic at the federal level.

Hiring slowed to a crawl in February, with payrolls growing by just 20,000. That came even though the BLS said there were 7.3 million job openings against just 6.3 million considered unemployed in December, the most recent month for which data were available.

Aurora Cannabis chair talks Peltz appointment and the future of the cannabis industry   8:56 AM ET Wed, 13 March 2019 | 05:34

“Amid the roiling debate over American jobs, the legal cannabis industry remains a substantial and unrecognized engine of grassroots job creation,” the report’s authors wrote. “In 2019, America’s cannabis industry is one of the nation’s greatest economic success stories. That success deserves to be recognized and celebrated.”

The document was written by Bruce Barcott, Leafly’s deputy editor, and Whitney Economics founder Beau Whitney.

Because there is no official count the report had to use some unconventional methods to estimate the jobs total. They utilized state data, industry surveys, information from operators, proprietary data and other economic formulas.

What they found was stunning: a 44 percent gain in the workforce for 2018 that came on top of a 21 percent increase the previous year.

At 211,000, the total number of jobs compares favorably to other more mainstream occupations: there were 131,430 chefs in the country, for instance, along with 65,760 aerospace engineers and 40,000 computer operators, according to the most recent BLS counts.

“US marijuana legalization is a rare example of disruption creating jobs rather than destroying them,” Nick Colas, co-founder of DataTrek Research, said in a note Thursday that highlighted some of the cannabis jobs data. “With the US labor market recently showing signs of weakness and fears of an eventual recession in the wings, this is one industry that might soften the blow of an economic downturn.”

Colas expects pot-related job creation to continue as more states legalize the substance. He called cannabis “the fastest-growing labor market in the U.S.”

In recent days, New Jersey officials unveiled a plan that would legalize marijuana and set up a taxation structure. New York also has plans underway to add to the roster of 10 states that already have gone the legalization route. Sen. Cory Booker, a New Jersey Democrat and presidential candidate for the 2020 election, introduced a bill a few weeks ago that would legalize marijuana nationally.

Along with the bottom-line gains, the industry’s growth also offers an alternative to the push for young Americans to get a college degree, which has led to an explosion of student loan debt that now totals nearly $1.6 trillion.

“Americans with a college degree are basically at full employment, but most Americans do not have those credentials and their participation rates are lower than the former,” Colas wrote. “The marijuana industry offers solid paying positions at all levels of experience and educational attainment.”

Colas cited Glassdoor data showing that median pay in the cannabis industry is 11 percent above the median U.S. salary of $52,863. “Budtenders,” the staff members who work directly with customers, generally earn $12 to $16 an hour, according to the site that allows current and former employees to review their workplaces and list typical salaries.

At the other end of the spectrum, cultivation and extraction directors and outside sales representatives can earn well into six figures.

Source: https://www.cnbc.com/2019/03/14/the-marijuana-industry-looks-like-the-fastest-growing-job-market-in-the-country.html

INTERVIEW: NORTHBUD $NBUD.ca Discusses Binding LOI For Acquisition of Multi-State Licensed Operator Eureka Vapor $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 1:37 PM on Tuesday, March 12th, 2019

NORTHBUD (NBUD:CSE) is already a late stage applicant at the “Confirmation of Readiness” stage for 25,000 square feet of indoor and 500,000 square feet of outdoor growing space, for the sole purpose of growing GMP pharma-grade cultivation and food-grade extracted inputs.

But Ryan Brown didn’t get this far in the cannabis space by sitting still … and he has made one hell of a great deal with the $20 MILLION acquisition of Eureka Vapor, a multi-state licensed operator in the USA.  The acquisition is subject to typical closing and due diligence but Ryan has a close relationship with the CEO and is confident it will close.

If and when it does close, Eureka will bring about $11.5 million in revenue at a 16% profit margin, which will be immediately accretive to the bottom line of NORTHBUD.  Accretive is actually an understatement.

I also love this acquisition because of its’ terms, which shows the confidence that both sides have in each other.  For example, the Eureka team can earn an extra $25 million if they hit certain milestones.  That says a lot about how Eureka may grown once it is a part of NORTHBUD.

On the flipside, the Eureka group only gets 10% of their shares on closing, with the rest dripped out over the next 24 months. That says a lot about the confidence Eureka has in NORTHBUD.

Find out more about NORTHBUD and this great deal in this interview with Ryan, who has already made a name for himself and is now on his way to growing that success, pun intended.

North Bud Farms $NBUD.ca Clarifies Terms of Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:35 PM on Thursday, March 7th, 2019
  • Clarifies the terms of its press release dated March 6, 2019 with respect to entering into the March 3, 2019 binding letter of intent

TORONTO, March 07, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) clarifies the terms of its press release dated March 6, 2019 with respect to entering into the March 3, 2019 binding letter of intent (“LOI”) to acquire all the issued and outstanding shares of Eureka Vapor LLC. and all of its subsidiaries (“Eureka”), a U.S. multi-state cannabis operator, and arm’s length to the Company, in a transaction valued at CAD$20 million (the “Transaction”). The completion of the Transaction is subject to the following conditions precedent: (i) obtaining the necessary board of director and shareholder approval of the Company and Eureka; (ii) the Company and Eureka satisfying respective due diligence of the other on or before May 30, 2019; (iii) entering into of a definitive agreement (the “Definitive Agreement”) in respect of the Transaction; and (iv) obtaining necessary regulatory and CSE approval. The Company and Eureka shall use commercially reasonable best efforts to satisfy the aforementioned condition precedents as soon as possible, but in any event no later than June 1, 2019 (the “Termination Deadline”) or another date as may be agreed to by the parties. In the event that the conditions precedent have not been satisfied or waived prior to the Termination Deadline, the LOI will automatically terminate.

As referenced in its March 6, 2019 press release, the purchase price of Eureka under the Definitive Agreement will be satisfied by the issuance of common shares (“Common Shares”) of the Company to Eureka shareholders with a price per Common Share to be determined based on a formula of the higher of (a) CAD$0.35 per Common Share; and (b) the 30 day volume weighted average price of the Common Shares. 10% of the Common Shares will be issued to the Eureka shareholders on the closing date of the Transaction (the “Closing Date”), with the remainder of Common Shares issued in equal tranches of six, twelve, eighteen, and twenty-four months from the Closing Date. In addition, Eureka shareholders are eligible to receive up to an additional CAD$25 million of Common Shares based on the achievement of USD$25 million of revenue derived from existing Eureka California and Colorado operations.

The 10% of the Common Shares issued on the Closing Date will represent up to 9.33% of the total issued and outstanding Common Shares on the Closing Date (if the minimum issuance price of CAD$0.35 per Common Share is assumed and there is no occurrence of dilutive events). The Company will issue a comprehensive press release respecting the terms of the Definitive Agreement upon entering into the Definitive Agreement.

The Company anticipates its common shares will re-commence trading after the dissemination of this news release.
           
About Eureka Vapor LLC.
Headquartered in Los Angeles, California, EUREKA Vapor was founded in 2011 and holds licenses in both California and Colorado.  EUREKA Vapor’s multi state operation manufactures and sells a premium line of vaporizer cartridges, disposable vapor pens and proprietary vaporizer batteries designed to work with their highly sought-after CO2 extracted oil.  Using their refined extraction processes and techniques developed over almost a decade of extracting, EUREKA Vapor is committed to providing the cleanest and safest natural oil cartridges in the industry.  Long referred to as one of the leaders in the industry, EUREKA has one of the most loyal customer bases in the category which reflects their commitment to honesty and transparency above all else. EUREKA continually looks for innovative ways to improve and refine their product offerings in order to deliver the best, most consistent vaping experience in the industry. 

For more information visit: www.eurekavapor.com

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly-owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act.  The Company is constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements including those relating to the Transaction, the completion of conditions precedent to the Transaction, entering into of the Definitive Agreement, the potential termination of the LOI, the issuance of Common Shares to Eureka shareholders, an issuance price of CAD$0.35 per Common Share at the Closing Date, Eureka achieving USD$25 million of revenue derived from California and Colorado operations, and the issuance of up to CAD$25 million of Common Shares, and the re-commencement of the trading of common shares of the Company. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms Inc.’s final long form prospectus dated August 21, 2018 which is available under the issuer’s SEDAR profile at www.sedar.com.  

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

CLIENT FEATURE: North Bud Farms $NBUD.ca sustainable low cost, high quality cannabinoid production and procurement $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 1:53 PM on Monday, March 4th, 2019

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
    As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
  • Announced Creation of “1017” Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line

THE OPPORTUNITY

  • Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
  • GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
  • Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
  • Phase 1 is located on 95 acres of agricultural farmland in Low, Québec.
  • Option exists to acquire more land if needed
  • Facility will focus on GMP (higher production grade) pharma-grade cultivation and food-grade extracted inputs

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: North Bud Farms is an advertising client of AGORA Internet Relations Corp.